The online pharmacy is also in talks to restructure debt terms ahead of rights issue; share sale set to open on September 4

Goldman Sachs is likely to convert some of its loan to online pharmacy PharmEasy into equity. Buoyed by binding commitments from existing i...

The Tata Group is set to become the first Indian company to assemble Apple’s iPhone. The conglomerate is close to a deal to acquire Apple s...

A down round is when a privately held firm raises funds at a valuation lower than that ascribed in the previous round.

PharmEasy is faced with a steep cut in its valuation, with the new funding round pegging its shares at Rs 5 each compared to the Rs 50 per ...

This week’s ETtech newsbreak on PharmEasy going for a rights issue at a price 90% lower than its peak valuation of $5.6 billion to repay de...

Mumbai-based epharmacy platform PharmEasy is likely to be valued at $500-600 million compared to the $5.6 billion valuation in 2021

The online drugstore plans to swallow a bitter pill in the hope that it can heal itself. The distress rights issue, if it goes through, wil...

Earlier in the day we broke the news that PharmEasy’s investors have taken control of the company as they plan a Rs 2,400 crore rights issu...

The aftermath of Covid-19 and the subsequent moratorium on loan repayments burnt a massive hole in the loan books of lenders. While the lar...

Online pharmacy PharmEasy recorded a positive ebitda of around Rs 14 crore, which means it is operationally profitable, even as one of its ...

PharmEasy’s parent API Holdings has also delayed internal plans for a potential initial public offering (IPO) to 2025, the people privy to ...

From controversies and regulatory diktats to high-profile exits and en masse layoffs, 2022 was a turbulent year for the tech industry.

Musk began showing signs of buyer’s remorse shortly after the deal was announced, alleging that Twitter had misled him about the size of it...

The Mumbai-based firm is also stitching up a private financing round through a rights issue where company founders are expected to invest p...

Through strategic acquisitions in the healthcare space, the company seems to be aiming to create “a holistic healthcare ecosystem”. From th...

In today's ETtech Morning Dispatch newsletter: Pharmeasy and Cred are the newest entrants of India's startup unicorn club, BPM firms see hi...